Department of Pharmacy Practice, Oregon State University/Oregon Health & Science University College of Pharmacy, Portland, Oregon.
Oregon Health & Science University School of Nursing, Portland, Oregon.
J Am Geriatr Soc. 2019 Jun;67(6):1258-1262. doi: 10.1111/jgs.15860. Epub 2019 Mar 10.
To quantify the frequency and type of medication decisions on discharge from the hospital to hospice care.
Retrospective cohort study.
A 544-bed academic tertiary care hospital in Portland, Oregon.
A total of 348 adult patients (age ≥18 y) discharged to hospice care between January 1, 2010, and December 31, 2016.
Data were collected from an electronic repository of medical record data and a manual review of patients' discharge summaries. Our outcomes of interest were the frequency and type of medication decisions documented in patients' discharge summaries. Medication decisions were categorized as continuation, continuation but with changes in dose, route of administration, and/or frequency, discontinuation, and initiation of new medications. We also collected data on the frequency of patient/family in the participation of medication-related decisions.
Patients were prescribed a mean of 7.1 medications (standard deviation [SD] = 4.8) on discharge to hospice care. The most prevalent medications prescribed on discharge were strong opioids (82.5%), anxiolytics/sedatives (62.9%), laxatives (57.5%), antiemetics (54.3%), and nonopioid analgesics (45.4%). However, only 67.8% (213/341) of patients who were prescribed an opioid on discharge to hospice care were also prescribed a laxative. Discharging providers made a mean of 15.0 decisions (SD = 7.2) per patient of which 28.5% were to continue medications without changes, 6.7% were to continue medications with changes, 30.3% were to initiate new medications, and 34.5% were to discontinue existing medications. Patients and/or family members were involved in medication decisions during 21.6% of discharges; patients were involved in 15.2% of decisions.
Patients averaged more than 15 medication decisions on discharge to hospice care. However, it was rarely documented that patients and/or their families participated in these decisions. J Am Geriatr Soc, 2019.
量化从医院出院到临终关怀时的药物治疗决策的频率和类型。
回顾性队列研究。
俄勒冈州波特兰市的一家拥有 544 张病床的学术型三级护理医院。
2010 年 1 月 1 日至 2016 年 12 月 31 日期间,共 348 名(年龄≥18 岁)成年患者出院至临终关怀。
数据来自电子病历数据存储库和患者出院小结的手动审查。我们感兴趣的结果是记录在患者出院小结中的药物治疗决策的频率和类型。药物决策分为继续、继续但剂量、给药途径和/或频率改变、停药和开始新的药物。我们还收集了关于患者/家属参与药物相关决策的频率的数据。
患者出院时平均开了 7.1 种药物(标准差[SD]=4.8)。出院时最常开的药物是强阿片类药物(82.5%)、镇静剂/安定剂(62.9%)、泻药(57.5%)、止吐药(54.3%)和非阿片类镇痛药(45.4%)。然而,只有 67.8%(213/341)出院时开阿片类药物的患者也开了泻药。出院医生为每位患者做出了 15.0 项决策(SD=7.2),其中 28.5%是继续使用无变化的药物,6.7%是继续使用有变化的药物,30.3%是开始新的药物,34.5%是停止现有的药物。在 21.6%的出院中,患者和/或家属参与了药物决策;患者参与了 15.2%的决策。
患者平均在出院到临终关怀时要做出超过 15 项的药物治疗决策。然而,很少有记录表明患者和/或他们的家属参与了这些决策。美国老年学会杂志,2019 年。